Recombinant Cynomolgus B7-2/CD86 (C-His)

Recombinant Cynomolgus B7-2/CD86 (C-His)

SKU: BP180-10ug
Recombinant Cynomolgus CD86 is produced by our Mammalian expression system and the target gene encoding Tyr25-His239 is expressed with a 6His tag at the C-terminus.
  • Accession Number

  • Expression

    Human 293 Cells
  • Background

    T-lymphocyte activation antigen CD86 (B7-2) is a type I membrane protein that belongs to the B7 family. CD86 is highly expressed on activated antigen presenting cells. CD86 plays an essential role for T-lymphocyte proliferation and interleukin-2 production through binding CD28 or CTLA-4. It is also involved in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Additionally, the CD86 participates innate immune responses by activating NF-κB-signaling pathway in macrophages. CD86 thus is predicted to be a promising candidate for immune therapy.
  • Formulation

    Lyophilized from a 0.2 um filtered solution of PBS,5% Trehalose, pH7.4.
  • Packaging

  • ALTnames

    T-lymphocyte activation antigen CD86 isoform 1; Activation B7-2 antigen; CD86
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA